Here, we showed that ANKRD49 expression is positively related to glioma grade and manifests a significant prognosis difference between glioma samples and non-glioma samples, suggesting that ANKRD49 may be a prognosis predictor. This evidence concerns the gene ANKRD49 and central nervous system cancer.